Selective chemical labelling of natural T modifications in DNA by Hardisty, Robyn et al.
Selective Chemical Labeling of Natural T Modiﬁcations in DNA
Robyn E. Hardisty,† Fumiko Kawasaki,† Aleksandr B. Sahakyan,† and Shankar Balasubramanian*,†,‡,§
†Department of Chemistry, University of Cambridge, Lensﬁeld Road, Cambridge CB2 1EW, U.K.
‡Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K.
§School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, U.K.
*S Supporting Information
ABSTRACT: We present a chemical method to selec-
tively tag and enrich thymine modiﬁcations, 5-formyluracil
(5-fU) and 5-hydroxymethyluracil (5-hmU), found natu-
rally in DNA. Inherent reactivity diﬀerences have enabled
us to tag 5-fU chemoselectively over its C modiﬁcation
counterpart, 5-formylcytosine (5-fC). We rationalized the
enhanced reactivity of 5-fU compared to 5-fC via ab initio
quantum mechanical calculations. We exploited this
chemical tagging reaction to provide proof of concept
for the enrichment of 5-fU containing DNA from a pool
that contains 5-fC or no modiﬁcation. We further
demonstrate that 5-hmU can be chemically oxidized to
5-fU, providing a strategy for the enrichment of 5-hmU.
These methods will enable the mapping of 5-fU and 5-
hmU in genomic DNA, to provide insights into their
functional role and dynamics in biology.
The DNA alphabet includes several modiﬁed nucleobasesthat exist above and beyond the four canonical bases in
the genomes of living systems.1 The ability to detect and map
such modiﬁcations is essential to understand their functional
role. Chemical approaches for detecting and mapping cytosine
(C) modiﬁcations (Figure 1a) have been developed to elucidate
their function.2 However, the biological role of the analogous
thymine (T) modiﬁcations, 5-formyluracil (5-fU) and 5-
hydroxymethyluracil (5-hmU) (Figure 1a), has been largely
unexplored due to the lack of methods to detect and map these
modiﬁcations.3 Both 5-fU and 5-hmU are oxidative lesions that
occur in mammalian DNA4 and may play an important role in
disease. The occurrence of 5-fU has been shown to cause
mutagenesis in mammalian cells,5,6 while elevated levels of 5-
hmU in the blood are associated with cancer.7,8 Furthermore,
the presence of both 5-fU and 5-hmU in synthetic oligomer
nucleotides (ODNs) has been shown to perturb DNA−protein
interactions and transcription factor binding.9,10 Recently, it has
also been shown that 5-hmU is generated by ten-eleven
translocation (TET) enzyme mediated oxidation of T in
mammalian stem cells and hence could have a potential role in
gene regulation.4 Herein, we describe a method to chemically
tag 5-fU and 5-hmU to provide a strategy to detect and enrich
DNA containing these modiﬁcations. Enriched fragments can
ultimately be sequenced and aligned against the genome to
provide a positional map of where such bases occur, which is
critical for understanding their function.11−13
We envisaged that the reactive aldehyde functionality on 5-
fU could be reacted with a biotinylated probe, analogous to the
chemistry previously used to tag 5-fC.11,14 However, to enable
the selective enrichment of T modiﬁcations, a chemoselective
method to distinguish between the aldehyde groups of 5-fU and
5-fC was required (Figure 1b).
To explore diﬀerences in reactivity between the formylated
bases, we subjected ODNs that contained either 5-fU (fU-
ODN) or 5-fC (fC-ODN) (Figure 2a) to a range of
condensation reactions with biotinylated probes 1, 2, or 3
(Figure 2b). Oxyamine 1, used previously for 5-fC enrich-
ment,11,14 can condense on the aldehyde to form an oxime,15,16
while the less nucleophilic acyl hydrazide 2 can react with
formyl groups to form a hydrazone.16,17 Furthermore, o-
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Figure 1. (a) Cytosine and analogous thymine modiﬁcations found in
DNA. (b) Chemoselective tagging of 5-fU.
Figure 2. (a) Sequences of fU-ODN and fC-ODN, and (b)
biotinylated oxyamine 1, biotinylated hydrazide linker 2, biotinylated
o-phenylenediamine linker 3.
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phenylenediamine has been shown to react with the 5-fU
mononucleoside to form a stable benzimidazole.18 In order to
exploit this chemistry for tagging and subsequent enrichment,
we designed a biotinylated o-phenylenediamine linker 3, which
was also able to react with 5-fU in a DNA context.
It was found that 5-fU showed greater reactivity than 5-fC
(Table 1), providing the basis for selective tagging of T
modiﬁcations. Previously reported conditions for reacting 5-fC
with 1 (Figure 2b)11 require more acidic conditions (pH 5) and
the presence of a nucleophilic catalyst p-anisidine (Table 1,
entry 1). In contrast, reaction with 5-fU was achievable under
less acidic conditions (pH 6) in the absence of catalyst (Table
1, entry 3). Further optimization with a reduced reaction time
led to the absence of detectable 5-fC reaction via LC−MS
analysis (Table 1, entry 4). Reaction of 5-fU with 2 showed a
similar trend in reactivity, although quantitative biotinylation
was possible at pH 7 with this probe (Table 1, entries 5−7).
Selectivity for 5-fU over 5-fC was also observed when using o-
phenylenediamine biotinylated linker 3 (Table 1, entry 8).
To rationalize the reactivity diﬀerences observed between 5-
fU and 5-fC, we performed ab initio quantum mechanical
calculations on reduced model systems (Supporting Informa-
tion, Section 5). We revealed the core electronic factor that
deﬁnes the increased reactivity of 5-fU, with respect to 5-fC, to
be the decreased stability (by 7.71 kcal/mol) of the C−C
bonding orbital between the carbons of the aldehyde group and
the nucleobase ring. This facilitates the pyramidalization of the
aldehyde carbon and formation of the transient C−N bond
upon hemiaminal formation (Figure 3a). Furthermore, when
considering the transient structures involving the 5-fU model,
we located an energy minimum upon the interaction with the
incoming nucleophile and a water molecule (Figure 3b and
Supporting Information, Section 5). The identiﬁed intermedi-
ate structure is more stable (ΔE = −13.79 kcal/mol) than the
system of non-interacting individual molecules, which may
further explain the enhanced reactivity for 5-fU observed over
its cytosine counterpart.
To demonstrate that DNA containing 5-fU can be selectively
enriched, we carried out experiments exploiting the selective
reactions developed for probes 1, 2, and 3. A double-stranded
80-mer bearing two modiﬁcations per strand was used as a
model for 5-fU (fU-DNA), while an analogous ODN
containing 5-fC (fC-DNA) and a non-modiﬁed ODN
(GCAT-DNA) were used as controls (Supporting Information,
Table S1). These ODNs were subjected to the biotinylation
reaction followed by aﬃnity enrichment using streptavidin-
coated magnetic beads. fU-DNA was enriched over fC-DNA by
∼150-fold with each probe, deﬁned by qPCR quantitation
(Supporting Information, Figure S4). A similar level of
enrichment was observed for fU-DNA over non-modiﬁed
GCAT-DNA, indicating that captured fC-DNA was at the
background level and hence unlikely to be due to covalent
reactivity of 5-fC with the biotinylated probes.
The 5-fU tagging strategy would serve as an important tool
to provide a positional map of T modiﬁcations, which is
required for understanding their biological role. This is
particularly useful in mammalian tissue, where 5-fU and 5-fC
occur at very similar levels.4 This robust method can therefore
be used for the speciﬁc enrichment of 5-fU, distinct from 5-fC,
to determine its localized position in the genome. In addition,
the strategy can also be extended for the mapping of 5-hmU.
We demonstrated the clean oxidation of 5-hmU to 5-fU using
KRuO4, utilizing conditions originally developed for the
oxidation of 5-hmC (Scheme 1).19,20 The completion of
oxidation was conﬁrmed by LC−MS analysis of a 5-hmU
containing ODN and mononucleoside composition analysis
(Supporting Information, Figure S28). The resultant 5-fU can
be subsequently tagged by exploiting the same selective
chemistry.
He and co-workers recently reported a method to selectively
enrich 5-hmU:G mispairs utilizing a chemoenzymatic glyco-
sylation.21 Our 5-fU tagging strategy following 5-hmU
oxidation would be useful to enrich 5-hmU in both matched
and mismatched contexts. In particular, this is important for the
Table 1. Reaction Conditions and % of Biotinylation of fU-
ODN and fC-ODN with Diﬀerent Probes
probe conditionsa fU-ODNb (%) fC-ODNb (%)
1 1c p-anisidinef, pH 5, 24 h >99 94
2 1 pH 5, 24 h >99 56
3 1 pH 6, 24 h >99 3
4 1 pH 6, 4 h 98 n.d.g
5 2d p-anisidinef, pH 6, 24 h >99 99
6 2 pH 7, 24 h >99 2
7 2 pH 7, 4 h >99 n.d.g
8 3e pH 7, 4 h 93 1
aReactions were carried out in 40 mM NH4OAc (entry 1) or in 40
mM sodium phosphate (entries 2−8). bConversion was calculated by
integration of UV signals of the biotinylated product and the starting
material at 260 nm. cProbe 1 was used at 0.4 mM. dProbe 2 was used
at 10 mM. eProbe 3 was used at 5 mM. fp-Anisidine was used at 100
mM. gn.d. = not detected.
Figure 3. (a) Reduced model systems of 5-formyl-1-methyl uracil (5-
fUm), methylamine, and water used in this study. (b) The identiﬁed
intermediate state along the pathway of hemiaminal formation with 5-
fUm. A 6-membered hydrogen transfer transient ring is formed, with
the carbon of the aldehyde group partially becoming tetrahedral upon
the C−N bond formation. All the outlined distances are in Å.
Scheme 1. 5-hmU Can Be Chemically Oxidized to 5-fU
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study of 5-hmU in mammalian cells, where it has been shown
that all detectable steady-state 5-hmU exists in a hmU:A base-
pair context.4
In conclusion, we demonstrate a method to selectively enrich
fragments containing T modiﬁcations in DNA by exploiting the
chemoselective reactivity of the aldehyde present in 5-fU. Our
method will help to further elucidate any potential role,
function or consequence of such modiﬁed bases in DNA.
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